613 filings
Page 2 of 31
PX14A6G
fxcxooflsmf74 fm
18 May 23
Letter to shareholders
4:46pm
DEFA14A
ns7oo qk5z6fmuc41jjo
17 May 23
Additional proxy soliciting materials
4:04pm
8-K
9uvds
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
ARS
ljcb1a
21 Apr 23
Annual report to shareholders
4:09pm
DEFA14A
si8f j0guueupaeao
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
qtmdu2rx8zdxdbd
17 Apr 23
Departure of Directors or Certain Officers
7:37am
8-K
0avtgrhk
10 Apr 23
Results of Operations and Financial Condition
7:01am
8-K
vugt7q88xed4e p5
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
d65ybbyxr2
3 Feb 23
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
7:06am
8-K
z5x85
9 Jan 23
J.P. Morgan Healthcare Conference 2023 Strategy & Business Update 2 Leonard S. Schleifer, MD, PhD Co - Founder, President & Chief Executive Officer
8:49am
8-K
yjduiopn
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm
UPLOAD
6aaqrky
7 Nov 22
Letter from SEC
12:00am
8-K
zoa nh4bb26a3edzqx
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
CORRESP
8urzeoni
7 Oct 22
Correspondence with SEC
12:00am
8-K
ig12hlli8s58bdrb tz
3 Oct 22
Departure of Directors or Certain Officers
7:17am
UPLOAD
dx6gi0kz3u4pj lt86
21 Sep 22
Letter from SEC
12:00am